17:26 EDT Adverum Biotechnologies files $200M mixed securities shelf
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADVM:
- Brexit Uncertainty: Navigating New Risks and Regulatory Hurdles for Adverum Biotechnologies
- Adverum Biotechnologies price target lowered to $2 from $3 at RBC Capital
- Adverum Biotechnologies reports Q4 EPS (23c), consensus (34c)
- Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pipeline Highlights and Corporate Updates
- Adverum Biotechnologies files to sell 106.48M shares of common stock for holders
Questions or Comments about the article? Write to editor@tipranks.com